#AANAM – Measuring Blood Proteins Could Predict Disability in SPMS

#AANAM – Measuring Blood Proteins Could Predict Disability in SPMS

292267

#AANAM – Measuring Blood Proteins Could Predict Disability in SPMS

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Among people with secondary progressive multiple sclerosis (SPMS) without active disease, high blood levels of the proteins neurofilament light chain, known as NfL, and glial fibrillary acidic protein, or GFAP, are associated with an increased risk of worsening disability, new research shows. The findings were…

You must be logged in to read/download the full post.